Local Anaesthesia Decreases Nerve Growth Factor Induced Masseter Hyperalgesia

Overview

Journal Sci Rep

Specialty Science

Date 2020 Sep 23

PMID 32963266

Citations 3

Authors

Yuri M Costa

Fernando G Exposto

Eduardo E Castrillon

Paulo Cesar R Conti

Leonardo R Bonjardim

Peter Svensson

Affiliations

Soon will be listed here.

Abstract

The aim of this investigation was to evaluate the effects of local anaesthesia on nerve growth factor (NGF) induced masseter hyperalgesia. Healthy participants randomly received an injection into the right masseter muscle of either isotonic saline (IS) given as a single injection (n = 15) or an injection of NGF (n = 30) followed by a second injection of lidocaine (NGF + lidocaine; n = 15) or IS (NGF + IS; n = 15) in the same muscle 48 h later. Mechanical sensitivity scores of the right and left masseter, referred sensations and jaw pain intensity and jaw function were assessed at baseline, 48 h after the first injection, 5 min after the second injection and 72 h after the first injection. NGF caused significant jaw pain evoked by chewing at 48 and 72 h after the first injection when compared to the IS group, but without significant differences between the NGF + lidocaine and NGF + IS groups. However, the mechanical sensitivity of the right masseter 5 min after the second injection in the NGF + lidocaine group was significantly lower than the second injection in the NGF + IS and was similar to the IS group. There were no significant differences for the referred sensations. Local anaesthetics may provide relevant information regarding the contribution of peripheral mechanisms in the maintenance of persistent musculoskeletal pain.

Citing Articles

Optimal Delivery of Pain Management in Schwannomatosis: A Literature Review.

Hino U, Tamura R, Toda M Ther Clin Risk Manag. 2025; 21():61-68.

PMID: 39839825 PMC: 11748755. DOI: 10.2147/TCRM.S362794.

Intramuscular injection of nerve growth factor as a model of temporomandibular disorder: nature, time-course, and sex differences characterising the pain experience.

Schabrun S, Si E, Millard S, Chiang A, Chen S, Chowdhury N Neurobiol Pain. 2023; 13:100117.

PMID: 36687467 PMC: 9852786. DOI: 10.1016/j.ynpai.2023.100117.

Long-Term Intranasal Nerve Growth Factor Treatment Favors Neuron Formation in Brain Tissue.

Colitti N, Desmoulin F, Friec A, Labriji W, Robert L, Michaux A Front Cell Neurosci. 2022; 16:871532.

PMID: 35928573 PMC: 9345199. DOI: 10.3389/fncel.2022.871532.

Preclinical models of deep craniofacial nociception and temporomandibular disorder pain.

Okamoto K, Hasegawa M, Piriyaprasath K, Kakihara Y, Saeki M, Yamamura K Jpn Dent Sci Rev. 2021; 57:231-241.

PMID: 34815817 PMC: 8593658. DOI: 10.1016/j.jdsr.2021.10.002.

References

Andersen H, Arendt-Nielsen L, Svensson P, Danneskiold-Samsoe B, Graven-Nielsen T . Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans. Exp Brain Res. 2008; 191(3):371-82. DOI: 10.1007/s00221-008-1531-5. View

Exposto F, Masuda M, Castrillon E, Svensson P . Effects of nerve growth factor experimentally-induced craniofacial muscle sensitization on referred pain frequency and number of headache days: A double-blind, randomized placebo-controlled study. Cephalalgia. 2018; 38(14):2006-2016. DOI: 10.1177/0333102418758481. View

Svensson P, Wang K, Arendt-Nielsen L, Cairns B . Effects of NGF-induced muscle sensitization on proprioception and nociception. Exp Brain Res. 2008; 189(1):1-10. DOI: 10.1007/s00221-008-1399-4. View

Svensson P, Wang M, Dong X, Kumar U, Cairns B . Human nerve growth factor sensitizes masseter muscle nociceptors in female rats. Pain. 2010; 148(3):473-480. DOI: 10.1016/j.pain.2009.12.009. View

Svensson P, Cairns B, Wang K, Arendt-Nielsen L . Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain. 2003; 104(1-2):241-7. DOI: 10.1016/s0304-3959(03)00012-5. View

Arendt-Nielsen L, Graven-Nielsen T . Translational musculoskeletal pain research. Best Pract Res Clin Rheumatol. 2011; 25(2):209-26. DOI: 10.1016/j.berh.2010.01.013. View

Svensson P . What can human experimental pain models teach us about clinical TMD?. Arch Oral Biol. 2007; 52(4):391-4. DOI: 10.1016/j.archoralbio.2006.11.015. View

Svensson P, Graven-Nielsen T . Craniofacial muscle pain: review of mechanisms and clinical manifestations. J Orofac Pain. 2001; 15(2):117-45. View

Denk F, Bennett D, McMahon S . Nerve Growth Factor and Pain Mechanisms. Annu Rev Neurosci. 2017; 40:307-325. DOI: 10.1146/annurev-neuro-072116-031121. View

10.

Hoheisel U, Reuter R, de Freitas M, Treede R, Mense S . Injection of nerve growth factor into a low back muscle induces long-lasting latent hypersensitivity in rat dorsal horn neurons. Pain. 2013; 154(10):1953-1960. DOI: 10.1016/j.pain.2013.05.006. View

11.

Obreja O, Rukwied R, Nagler L, Schmidt M, Schmelz M, Namer B . Nerve growth factor locally sensitizes nociceptors in human skin. Pain. 2017; 159(3):416-426. DOI: 10.1097/j.pain.0000000000001108. View

12.

Petruska J, Mendell L . The many functions of nerve growth factor: multiple actions on nociceptors. Neurosci Lett. 2004; 361(1-3):168-71. DOI: 10.1016/j.neulet.2003.12.012. View

13.

Wong H, Kang I, Dong X, Christidis N, Ernberg M, Svensson P . NGF-induced mechanical sensitization of the masseter muscle is mediated through peripheral NMDA receptors. Neuroscience. 2014; 269:232-44. DOI: 10.1016/j.neuroscience.2014.03.054. View

14.

Karadas O, Gul H, Inan L . Lidocaine injection of pericranial myofascial trigger points in the treatment of frequent episodic tension-type headache. J Headache Pain. 2013; 14:44. PMC: 3671170. DOI: 10.1186/1129-2377-14-44. View

15.

Laursen R, Graven-Nielsen T, Jensen T, Arendt-Nielsen L . The effect of differential and complete nerve block on experimental muscle pain in humans. Muscle Nerve. 1999; 22(11):1564-70. DOI: 10.1002/(sici)1097-4598(199911)22:11<1564::aid-mus12>3.0.co;2-3. View

16.

Rubin T, Gandevia S, Henderson L, Macefield V . Effects of intramuscular anesthesia on the expression of primary and referred pain induced by intramuscular injection of hypertonic saline. J Pain. 2009; 10(8):829-35. DOI: 10.1016/j.jpain.2009.01.327. View

17.

Staud R, Nagel S, Robinson M, Price D . Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain. 2009; 145(1-2):96-104. PMC: 2751583. DOI: 10.1016/j.pain.2009.05.020. View

18.

Staud R, Weyl E, Bartley E, Price D, Robinson M . Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome. Eur J Pain. 2013; 18(6):803-12. PMC: 4010579. DOI: 10.1002/j.1532-2149.2013.00422.x. View

19.

Gerber R, Nie H, Arendt-Nielsen L, Curatolo M, Graven-Nielsen T . Local pain and spreading hyperalgesia induced by intramuscular injection of nerve growth factor are not reduced by local anesthesia of the muscle. Clin J Pain. 2010; 27(3):240-7. DOI: 10.1097/AJP.0b013e3182048481. View

20.

Al-Moraissi E, Alradom J, Aladashi O, Goddard G, Christidis N . Needling therapies in the management of myofascial pain of the masticatory muscles: A network meta-analysis of randomised clinical trials. J Oral Rehabil. 2020; 47(7):910-922. DOI: 10.1111/joor.12960. View